Fortin J - Search Results

1

No Evidence of BRCA1/2 genomic rearrangements in high-risk French-Canadian breast/ovarian cancer families.

Moisan AM, Fortin J, Dumont M, Samson C, Bessette P, Chiquette J, Laframboise R, Lépine J, Lespérance B, Pichette R, Plante M, Provencher L, Voyer P, Goldgar D, Bridge P, Simard J. Moisan AM, et al. Among authors: fortin j. Genet Test. 2006 Summer;10(2):104-15. doi: 10.1089/gte.2006.10.104. Genet Test. 2006. PMID: 16792513

2

A new alternative splice variant of BRCA1 containing an additional in-frame exon.

Fortin J, Moisan AM, Dumont M, Leblanc G, Labrie Y, Durocher F, Bessette P, Bridge P, Chiquette J, Laframboise R, Lépine J, Lespérance B, Pichette R, Plante M, Provencher L, Voyer P, Simard J. Fortin J, et al. Biochim Biophys Acta. 2005 Oct 15;1731(1):57-65. doi: 10.1016/j.bbaexp.2005.08.011. Epub 2005 Sep 13. Biochim Biophys Acta. 2005. PMID: 16185777

3

The transcription factor Egr1 regulates the HIF-1alpha gene during hypoxia.

Sperandio S, Fortin J, Sasik R, Robitaille L, Corbeil J, de Belle I. Sperandio S, et al. Among authors: fortin j. Mol Carcinog. 2009 Jan;48(1):38-44. doi: 10.1002/mc.20454. Mol Carcinog. 2009. PMID: 18506761

4

[Games of chance and gambling in adolescents and in adolescents-at-risk].

Fortin JM, Ladouceur R, Pelletier A, Ferland F. Fortin JM, et al. Can J Commun Ment Health. 2001 Spring;20(1):135-51. Can J Commun Ment Health. 2001. PMID: 11599132 French.

5

R5 and X4 HIV viruses differentially modulate host gene expression in resting CD4+ T cells.

Sirois M, Robitaille L, Sasik R, Estaquier J, Fortin J, Corbeil J. Sirois M, et al. Among authors: fortin j. AIDS Res Hum Retroviruses. 2008 Mar;24(3):485-93. doi: 10.1089/aid.2007.0120. AIDS Res Hum Retroviruses. 2008. PMID: 18327980

6

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.

Parker CC, Clarke NW, Cook AD, Kynaston H, Catton CN, Cross WR, Petersen PM, Persad RA, Saad F, Bower LC, Logue J, Payne H, Forcat S, Goldstein C, Murphy C, Anderson J, Barkati M, Bottomley DM, Branagan J, Choudhury A, Chung PWM, Cogley L, Goh CL, Hoskin P, Khoo V, Malone SC, Masters L, Morris SL, Nabid A, Ong AD, Raman R, Tarver KL, Tree AC, Worlding J, Wylie JP, Zarkar AM, Parulekar WR, Parmar MKB, Sydes MR; RADICALS investigators. Parker CC, et al. Lancet. 2024 May 16:S0140-6736(24)00548-8. doi: 10.1016/S0140-6736(24)00548-8. Online ahead of print. Lancet. 2024. PMID: 38763154 Free article.

7

Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.

Parker CC, Kynaston H, Cook AD, Clarke NW, Catton CN, Cross WR, Petersen PM, Persad RA, Pugh CA, Saad F, Logue J, Payne H, Bower LC, Brawley C, Rauchenberger M, Barkati M, Bottomley DM, Brasso K, Chung HT, Chung PWM, Conroy R, Falconer A, Ford V, Goh CL, Heath CM, James ND, Kim-Sing C, Kodavatiganti R, Malone SC, Morris SL, Nabid A, Ong AD, Raman R, Rodda S, Wells P, Worlding J, Parulekar WR, Parmar MKB, Sydes MR; RADICALS investigators. Parker CC, et al. Lancet. 2024 May 16:S0140-6736(24)00549-X. doi: 10.1016/S0140-6736(24)00549-X. Online ahead of print. Lancet. 2024. PMID: 38763153 Free article.

8

Mutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendroglioma.

Spitzer A, Gritsch S, Nomura M, Jucht A, Fortin J, Raviram R, Weisman HR, Gonzalez Castro LN, Druck N, Chanoch-Myers R, Lee JJY, Mylvaganam R, Lee Servis R, Fung JM, Lee CK, Nagashima H, Miller JJ, Arrillaga-Romany I, Louis DN, Wakimoto H, Pisano W, Wen PY, Mak TW, Sanson M, Touat M, Landau DA, Ligon KL, Cahill DP, Suvà ML, Tirosh I. Spitzer A, et al. Among authors: fortin j. Cancer Cell. 2024 May 13;42(5):904-914.e9. doi: 10.1016/j.ccell.2024.03.008. Epub 2024 Apr 4. Cancer Cell. 2024. PMID: 38579724

9

First Constraints on the Photon Coupling of Axionlike Particles from Multimessenger Studies of the Neutron Star Merger GW170817.

Dev PSB, Fortin JF, Harris SP, Sinha K, Zhang Y. Dev PSB, et al. Among authors: fortin jf. Phys Rev Lett. 2024 Mar 8;132(10):101003. doi: 10.1103/PhysRevLett.132.101003. Phys Rev Lett. 2024. PMID: 38518339

10

Discovery of JNJ-1802, a First-in-Class Pan-Serotype Dengue Virus NS4B Inhibitor.

Kesteleyn B, Bonfanti JF, Bardiot D, De Boeck B, Goethals O, Kaptein SJF, Stoops B, Coesemans E, Fortin J, Muller P, Doublet F, Carlens G, Koukni M, Smets W, Raboisson P, Chaltin P, Simmen K, Loock MV, Neyts J, Marchand A, Jonckers THM. Kesteleyn B, et al. Among authors: fortin j. J Med Chem. 2024 Mar 14;67(5):4063-4082. doi: 10.1021/acs.jmedchem.3c02336. Epub 2024 Feb 28. J Med Chem. 2024. PMID: 38482827

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

484 results

Search Page